Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Bayer
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
Washington University School of Medicine
Hummingbird Bioscience
BioNTech SE
Astellas Pharma Inc
Novartis
Cancer Trials Ireland
National Cancer Institute (NCI)
Bristol-Myers Squibb
Janssen Research & Development, LLC
7 Hills Pharma, LLC
Janssen Research & Development, LLC
Tango Therapeutics, Inc.
National Cancer Institute (NCI)
Bristol-Myers Squibb
Janssen Research & Development, LLC
Genmab
Instituto Nacional de Cancerologia de Mexico
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Pfizer
Genmab
Cancer Research UK
DualityBio Inc.
Turning Point Therapeutics, Inc.
Servier
Servier
Verastem, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Therapex Co., Ltd
EMD Serono
Novartis
Astellas Pharma Inc
Tang-Du Hospital
Amgen
Aulos Bioscience, Inc.
AstraZeneca
Revolution Medicines, Inc.
Obsidian Therapeutics, Inc.
Radiopharm Theranostics, Ltd
3D Medicines
AstraZeneca
Shanxi Province Cancer Hospital
Hoffmann-La Roche
Regeneron Pharmaceuticals